A cannabis extraction facility announcement failed to impressed investors in a Canadian marijuana stock Wednesday. Here’s some small stocks making big moves on Wednesday, July 3, 2019 (as of 4 pm EST):
Westleaf Inc. (TSXV:WL), a Canadian marijuana stock, fell 13% to $0.55 on Wednesday after announcing the completion of construction on its wholly-owned cannabis extraction, processing and product formulation facility, The Plant by Westleaf Labs, which will have throughput capacity of up to 65,000 kilograms per year in Phase I. The Company added that the facility is now entering the final stages of the Health Canada licensing process and it expects to receive a Standard Processing license as early as Q3 2019.
As well, shares of Burcon NutraScience Corporation (TSX:BU) eased 4% to $0.67 as the developer of plant proteins said its fiscal 2019 revenue fell to $40,000 from $49,000, while its net loss for the year narrowed to $4.8 million from $5.6 million during fiscal 2018.
Sernova Corp. (TSXV:SVA), meanwhile, reported that in an interim analysis of its human Phase I/II clinical trial, Sernova’s Cell Pouch transplanted with islet cells showed initial safety, as well as key efficacy measures, including glucose-stimulated C-peptide, insulin production and additional clinically significant measures of glucose control in the first study patient with type-1 diabetes and severe hypoglycemia unawareness. Sernova stock moved up as much as 13% following the announcement.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Westleaf Inc. (TSXV:WL), a Canadian marijuana stock, fell 13% to $0.55 on Wednesday after announcing the completion of construction on its wholly-owned cannabis extraction, processing and product formulation facility, The Plant by Westleaf Labs, which will have throughput capacity of up to 65,000 kilograms per year in Phase I. The Company added that the facility is now entering the final stages of the Health Canada licensing process and it expects to receive a Standard Processing license as early as Q3 2019.
